IGHS Group and Consult Invest celebrate a contract for Central Asian Countries.
The IGHS signed today, in Tashkent, Uzbekistan, a contract with the multinational Consult Invest, for the representation of services and products of Idealmed GHS and its brand new biothech company, Innov-Cell Therapeutics, for the Central Asian Countries.
This contract includes the design, development and management of hospitals in Uzbekistan and Kazakhstan, as well as the pharmaceutical distribution of Innov-Cell Therapeutics products for all the regions of Central Asia.
For José Alexandre Cunha, Chairman of IGHS Group "the celebration of this contract, which has the strong support of the local governments, demonstrates a great recognition of IGHS work and projects developed in the international market and represents a huge opportunity in a region that has shown a unique growth. Once again, we are able to assume that from Portugal, and in particular from Coimbra, it’s possible to strengthen our skills in a such competitive sector.
IGHS & KELOCELL at the world's largest medical trade fair MEDICA 2023
As the world's largest medical trade fair, MEDICA brings together thousands of companies and tens of thousands of visitors each year in Düsseldorf, Germany to showcase the latest innovations in medical technology.Read more
IGHS & KELO.CELL at CPHI Worldwide 2023
From October 24th to 26th, Barcelona was the heart of pharmaceutical innovation, bringing together the biggest industry players and over 50,000 professionals from more than 170 countries.
CPHI is the world's leading trade fair for the Pharma community and has become a key platform for new connections, strategic partnerships, exchanging knowledge and exploring new opportunities.Read more